Expression of Etk/Bmx tyrosine kinase in intrahepatic cholangiocarcinoma

Journal of Surgical Oncology

Volumn 97, Issue 5, 2008, Pages 428-432

  Guo, Linlang ^a   Guo, Ying ^a   Xiao, Sha ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Bcl 2; Etk Bmx; Intrahepatic cholangiocarcinoma (ICC); NF B; PCNA

Indexed keywords

BONE MARROW X KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; PROTEIN TYROSINE KINASE; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TUMOR VOLUME;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL DIFFERENTIATION; CHOLANGIOCARCINOMA; GENES, BCL-2; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN-TYROSINE KINASES; SURVIVAL ANALYSIS; TRANSCRIPTION FACTOR RELA; VIRAL NONSTRUCTURAL PROTEINS;

EID: 41549110303     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20983     Document Type: Article

References (40)

1. Okuda K, Nakanuma Y, Miyazaki M: Cholangiocarcinoma: Recent progress. Part 1: Epidemiology and etiology. J Gastroenterol Hepatol 2002;17:1049-1055.
2. Gores GJ: Cholangiocarcinoma: Current concepts and insights. Hepatology 2003;37:961-969.
3. Shimonishi T, Sasaki M, Nakanuma Y: Precancerous lesions of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2000;7:542-550.
4. Donato F, Gelatti U, Tagger A, et al.: Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: A case-control study in Italy. Cancer Causes Control 2001;12:959-964.
5. Lu H, Ye MQ, Thung SN, et al.: Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients. Chin Med J (Engl) 2000;113:1138-1141.
6. Yin F, Chen B: Detection of hepatitis C virus RNA sequences in hepatic portal cholangiocarcinoma tissue by reverse transcription polymerase chain reaction. Chin Med J (Engl) 1998;111:1068-1070.
7. Reeves ME, Dematteo RP: Genes and viruses in hepatobiliary neoplasia. Semin Surg Oncol 2000;19:84-93.
8. Okuda K, Nakanuma Y, Miyazaki M: Cholangiocarcinoma: Recent progress. Part 2: Molecular pathology and treatment. J Gastroenterol Hepatol 2002;17:1056-1063.
9. Batheja N, Suriawinata A, Saxena R, et al.: Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis. Mod Pathol 2000;13:1265-1268.
10. Tannapfel A, Weinans L, Geibler F, et al.: Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver. Dig Dis Sci 2000;45:317-324.
11. Tamagnone L, Lahtinen I, Mustonen T, et al.: A novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. Oncogene 1994;9:3683-3688.
12. Smith CI, Islam TC, Mattsson PT, et al.: Tec family of cytoplasmic tyrosine kinases: Mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species. Bioessays 2001;23:436-446.
13. Qiu Y, Kung HJ: Signaling network of the Btk family kinases. Oncogene 2000;19:5651-5661.
14. Mano H: Tec family of protein-tyrosine kinases: An overview of their structure and function. Cytokine Growth Factor Rev 1999;10:267-280.
15. Wen X, Lin HH, Shih HM, et al.: Kinase activation of the non-receptor tyrosine kinase Etk/BMX alone is sufficient to transactivate STAT-mediated gene expression in salivary and lung epithelial cells. J Biol Chem 1999;274:38204-38210.
16. Robinson D, He F, Pretlow T, et al.: A tyrosine kinase profile of prostate carcinoma. Proc Natl Acad Sci USA 1996;93:5958-5962.
17. Lee LF, Guan J, Qiu Y, et al.: Independence in prostate cancer cells: Roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase. Mol Cell Biol 2001;21:8385-8397.
18. Qiu Y, Robinson D, Pretlow TG, et al.: Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc Natl Acad Sci USA 1998;95:3644-3649.
19. Xue LY, Qiu Y, He J, et al.: Etk/Bmx, a PH-domain containing tyrosine kinase, protects prostate cancer cells from apoptosis induced by photodynamic therapy or thapsigargin. Oncogene 1999;18:3391-3398.
20. Chen KY, Huang LM, Kung HJ, et al.: The role of tyrosine kinase Etk/Bmx in EGF-induced apoptosis of MDA-MB-468 breast cancer cells. Oncogene 2004;23:1854-1862.
21. Bagheri-Yarmand R, Mandal M, Taludker AH, et al.: Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells. J Biol Chem 2001;276:29403-29409.
22. Chau CH, Chen KY, Deng HT, et al.: Coordinating Etk/Bmx activation and VEGF upregulation to promote cell survival and proliferation. Oncogene 2002;21:8817-8829.
23. Guo L, Guo Y, Xiao S: Expression of Etk/Bmx tyrosine kinase in the tumorigenicity of nasopharyngeal epithelium and its relation with EB virus infection and the apoptosis-related protein Bcl-2. Cancer Lett 2006;232:255-261.
24. Bacuerle PA, Baltimore D: I kappa B: A specific inhibitor of the NF-kappa B transcription factor. Science (Washington, DC) 1998;242:540-546.
25. Grilli M, Chiu JJ, Lenardo MJ: NF-kappa B and Rel: Participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993;143:1-62.
26. Zhong H, Voll RE, Ghosh S: Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1998;1:661-671.
27. Perkins ND, Felzien LK, Betts JC, et al.: Regulation of NF-kappa B by cyclin-dependent kinases associated with the p300 coactivator. Science 1997;275:523-527.
28. Wang W, Abbruzzese JL, Evans DB, et al.: The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 1999;5:119-127.
29. Sasaki N, Morisaki T, Hashizume K, et al.: Nuclear factor-kB p65(RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 2001;7:4136-4142.
30. Yu L, Yu H, Yu J, et al.: Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue. World J Gastroenterol 2004;10:3255-3260.
31. Pallares J, Martinez-Guitarte J, Dolcet X, et al.: Abnormalities in the NF-kappaB family and related proteins in endometrial carcinoma. J Pathol 2004;204:569-577.
32. Shukla S, MacLennan G, Fu P, et al.: Nuclear factor-kappaB/p65 (Re1 A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia 2004;6:390-400.
33. Ruster B, Zeuzem S, Krump-Konvalinkova V, et al.: Comparative sequence analysis of the core- and NS5-region of hepatitis C virus from tumor and adjacent non-tumor tissue. J Med Virol 2001;63:128-134.
34. Chen MY, Huang ZQ, Chen LZ, et al.: Detection of hepatitis C virus NS5 protein and genome in Chinese carcinoma of the extrahepatic bile duct and its significance. World J Gastroenterol 2000;6:800-804.
35. Prosperi E: Multiple roles of the proliferating cell nuclear antigen: DNA replication, repair and cell cycle control. Prog Cell Cycle Res 1997;3:193-210.
36. Iwata M, Harada K, Kono N, et al.: Expression of Bcl-2 familial proteins is reduced in small bile duct lesions of primary biliary cirrhosis. Human Pathol 2000;31:179-184.
37. Charlotte F, L'Hermine A, Martin N, et al.: Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 1994;144:460-465.
38. Harnois DM, Que FG, Celli A, et al.: Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line. Hepatology 1997;26:884-890.
39. Saharinen P, Ekman N, Sarvas K, et al.: The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase C delta. Blood 1997;90:4341-4353.
40. Tsai YT, Su YH, Fang SS, et al.: Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation. Mol Cell Biol 2000;20:2043-2054.